A prospective study of the safety of joint and soft tissue aspirations and injections in patients taking warfarin sodium

Arthritis Rheum. 1998 Apr;41(4):736-9. doi: 10.1002/1529-0131(199804)41:4<736::AID-ART23>3.0.CO;2-P.

Abstract

Objective: To determine the safety of joint or soft tissue aspirations and injections in patients taking warfarin sodium.

Methods: The outcome of 32 joint or soft tissue aspirations or injections in patients receiving stable doses of warfarin sodium was assessed through a standardized interview 4 weeks after the procedure. The primary outcome measure was significant joint or soft tissue hemorrhage, ascertained by patient-reported increases in swelling or warmth at the procedure site.

Results: None of 32 procedures was complicated by joint or soft tissue hemorrhage reported by the patients, yielding, by the "rule of threes," a risk of significant hemorrhage of < 10% (with 95% certainty). Diagnostic information was obtained for 53% of aspirated sites (8 of 15) and therapeutic benefit was noted in 74% of corticosteroid-injected sites (17 of 23).

Conclusion: Joint or soft tissue injections and aspirations in selected patients taking warfarin sodium are associated with a low risk of hemorrhage and are often of diagnostic or therapeutic value.

Publication types

  • Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Aged, 80 and over
  • Anticoagulants / therapeutic use*
  • Arthritis / etiology
  • Bursitis / etiology
  • Connective Tissue / pathology
  • Evaluation Studies as Topic
  • Female
  • Hemarthrosis / etiology
  • Hemorrhage / drug therapy
  • Hemorrhage / etiology
  • Hemorrhage / prevention & control
  • Humans
  • Injections / adverse effects
  • Injections / methods
  • Injections / standards*
  • International Normalized Ratio / standards
  • Joints / pathology
  • Male
  • Middle Aged
  • Needles
  • Pain / etiology
  • Prospective Studies
  • Self-Assessment
  • Suction / adverse effects
  • Suction / methods
  • Suction / standards*
  • Warfarin / therapeutic use*

Substances

  • Anticoagulants
  • Warfarin